Gujarat Themis Biosyn Share Price

    NSE
    351.35
    +9.60 (2.89%)
    GUJTHEM • 04 Jul, 2025 | 03:29 PM
    BUY
    The current prices are delayed, login or Open Demat Account for live prices.

    Gujarat Themis Biosyn Stock Performance

    1W Return0.19
    1Y Return36,008.25
    Today's Low340
    Prev. Close341.75
    Mkt Cap (Cr.)3,816.51
    1M Return5.47
    3Y Return36,008.25
    52-Week High363.3
    Open345.00
    PE Ratio78.23
    6M Return36,008.25
    Today's High355.9
    52-Week Low208
    Face Value1

    Gujarat Themis Biosyn Company background

    Founded in: 1981
    Promoted byJayshree D Patel, Gujarat Themis Biosyn Limited was incorporated in 1981 as a joint sector company with Gujarat Industrial Investment Corporation Ltd (GIIC) and Chemosyn (P) Ltd. The Company commenced production in August 1985. It was subsequently taken over in June 1991 by Yuhan Group, South Korea and Pharmaceutical Business Group (India) Ltd. (PBG) a unique consortium of five competing drug companies Themis Medicare Ltd., Kopran Ltd., Anant Co., Cadila Health Care Ltd. (Zydus) and Lyka Labs Ltd. It is being actively managed by Themis Medicare Ltd. (JV company of Gedeon Richter Ltd, Hungary) since 2007.Initially manufacturing the antibiotic, erythromycin, GTBL obtained licences to manufacture bulk drugs like rifampicin, cephalexin, griseofulvin and their formulations in 1990. However, problems relating to purity levels, yield and imports put the company in the red and it became a BIFR case in 1990. Subsequently, it was taken over by a group consisting of Lyka Labs, Themis Chemicals, Kopran and Cadila. Also, Yuhan Corporation, South Korea, brought in technology and finance for running GTBL.During 199596 the paidup share capital increased from Rs 11.25 crores to Rs 11.60 crores after allotment of 350,000 Equity shares of Rs 10 each at a premium of Rs 20 per share to the financial institutions by way of conversion of fund interst term loan. During the year 201920, installed capacity of rifamysinS was increased to 90 mtpa and expansion of rifampicin was achieved to the maximum capacity of 120 mtpa. It also commenced operations of its new pharmaceutical division and launched a wide range of antituberculosis products and other antibiotics in 2022.The Company is presently in the business of manufacturing and sale of raw material by fermentation process.

    As of 04 Jul, 2025, Gujarat Themis Biosyn share price is ₹350.4. The stock opened at ₹344.8 and had closed at ₹341.3 the previous day. During today’s trading session, Gujarat Themis Biosyn share price moved between ₹340.00 and ₹355.90, with an average price for the day of ₹347.95. Over the last 52 weeks, the stock has recorded a low of ₹208.00 and a high of ₹363.30. In terms of performance, Gujarat Themis Biosyn share price has increased by 4.1% over the past six months and has increased by 40.37% over the last year.

    Read More
    View details of Market Depth

    Gujarat Themis Biosyn Fundamental

    Market Cap (in crs)

    3,816.51

    Face Value

    1

    Turnover (in lacs)

    1,000.50

    Key Metrics

    Qtr Change %
    82.19% Gain from 52W Low
    24.2
    Dividend yield 1yr %
    Low in industry
    0.05

    Top Mutual Fund Invested in Gujarat Themis Biosyn

    Promoter
    70.9%
    Foreign Institutions
    1.9%
    Mutual Funds
    1.2%
    Domestic Institutions
    1.2%
    Public
    26%
    Promoter
    70.9%
    Foreign Institutions
    1.4%
    Mutual Funds
    1.2%
    Domestic Institutions
    1.2%
    Public
    26.6%
    Promoter
    70.9%
    Foreign Institutions
    1.5%
    Mutual Funds
    1.2%
    Domestic Institutions
    1.2%
    Public
    26.5%
    Promoter
    70.9%
    Foreign Institutions
    1.4%
    Mutual Funds
    1.2%
    Domestic Institutions
    1.2%
    Public
    26.5%
    Promoter
    70.9%
    Foreign Institutions
    1%
    Mutual Funds
    0.8%
    Domestic Institutions
    0.9%
    Public
    27.3%
    Promoter
    70.9%
    Foreign Institutions
    0.9%
    Public
    28.2%

    Gujarat Themis Biosyn Technical Analysis

    Moving Averages Analysis
    351.35
    Current Price
    Bullish Moving Averages
    16
    Bearish Moving Averages
    0
    5Day EMA
    346.30
    10Day EMA
    343.20
    12Day EMA
    342.10
    20Day EMA
    337.40
    26Day EMA
    333.90
    50Day EMA
    321.40
    100Day EMA
    309.30
    200Day EMA
    300.10
    5Day SMA
    346.80
    10Day SMA
    343.00
    20Day SMA
    339.80
    30Day SMA
    331.20
    50Day SMA
    317.20
    100Day SMA
    290.80
    150Day SMA
    299.40
    200Day SMA
    306.60
    Delivery & Volume

    Delivery & Volume

    PeriodCombined Delivery VolumeNSE+BSE Traded Volume
    Day Rs
    166159 Rs
    310988 Rs
    Week Rs
    87169 Rs
    176982 Rs
    Month Rs
    144361 Rs
    271424 Rs
    348.83
    Pivot
    Resistance
    First Resistance
    357.67
    Second Resistance
    364.88
    Third Resistance
    373.72
    Support
    First Support
    341.62
    Second support
    332.78
    Third Support
    325.57
    Relative Strength Index
    59.45
    Money Flow Index
    80.60
    MACD
    8.18
    MACD Signal
    8.14
    Average True Range
    15.42
    Average Directional Index
    20.27
    Rate of Change (21)
    6.29
    Rate of Change (125)
    5.94
    Name
    Holding Percent
    Quant Mutual Fund - Quant Manufacturing Fund
    1.15

    Gujarat Themis Biosyn Latest News

    26 JUN 2025 | Thursday

    Gujarat Themis Biosyn Ltd - 506879 - Closure of Trading Window

    13 JUN 2025 | Friday

    Gujarat Themis Biosyn Ltd - 506879 - Announcement under Regulation 30 (LODR)-Change in Management

    13 JUN 2025 | Friday

    Gujarat Themis Biosyn Ltd - 506879 - Announcement Under Regulation 30 Of SEBI (LODR)- Withdrawal Of Scheme Of Amalgamation.

    View More

    Gujarat Themis Biosyn Share Price FAQs

    Gujarat Themis Biosyn share price is ₹351.35 in NSE and ₹351 in BSE as on 4/7/2025.

    Gujarat Themis Biosyn share price in the past 1-year return was 36008.24. The Gujarat Themis Biosyn share hit a 1-year low of Rs. 208 and a 1-year high of Rs. 363.3.

    The market cap of Gujarat Themis Biosyn is Rs. 3816.51 Cr. as of 4/7/2025.

    The PE ratios of Gujarat Themis Biosyn is 78.23 as of 4/7/2025.

    The PB ratios of Gujarat Themis Biosyn is 15.37 as of 4/7/2025

    The Mutual Fund Shareholding in Gujarat Themis Biosyn was 1.16% at the end of 4/7/2025.

    You can easily buy Gujarat Themis Biosyn shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

    The 52-week high and low of Gujarat Themis Biosyn share price is ₹363.3 and ₹208 as of 4/7/2025.

    Please be aware that Gujarat Themis Biosyn stock prices are subject to continuous fluctuations due to various factors.

    Popular Stocks
    65.53
    +0.26 (+0.40%)
    139.24
    -0.46 (-0.33%)
    689.05
    -1.35 (-0.20%)
    2,599.10
    -12.10 (-0.46%)
    166.67
    -0.85 (-0.51%)
    391.40
    +0.75 (+0.19%)
    163.01
    -2.90 (-1.75%)
    261.40
    +0.55 (+0.21%)
    427.55
    +1.30 (+0.30%)
    401.00
    +1.10 (+0.28%)
    Top Gainers
    925.30
    +15.15 (+1.66%)
    1,640.70
    +22.00 (+1.36%)
    1,307.40
    +16.10 (+1.25%)
    1,442.80
    +16.90 (+1.19%)
    270.05
    +3.00 (+1.12%)
    Top Losers
    5,456.00
    -735.00 (-11.87%)
    163.01
    -2.90 (-1.75%)
    5,629.00
    -87.00 (-1.52%)
    1,655.20
    -16.70 (-1.00%)
    12,646.00
    -106.00 (-0.83%)
    Open Demat Account
    +91 -

    Open Demat Account
    +91 -